Assetmark, Inc Horizon Therapeutics Public LTD CO Transaction History

Assetmark, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $12,138 - $14,159	126 Added 32.64%	512 $52,000
Q1 2023 May 05, 2023	SELL	$107.32 - $113.5 $75,338 - $79,677	-702 Reduced 64.52%	386 $42,000
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $3,431 - $6,259	55 Added 5.32%	1,088 $123,000
Q3 2022 Nov 01, 2022	BUY	$58.92 - $84.67 $7,718 - $11,091	131 Added 14.52%	1,033 $64,000
Q2 2022 Aug 03, 2022	BUY	$79.4 - $116.36 $44,861 - $65,743	565 Added 167.66%	902 $72,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $29,123 - $37,005	337 New	337 $35,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $172 - $191	-2 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $737 - $928	-11 Reduced 84.62%	2 $0
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $468,460 - $677,966	-8,482 Reduced 99.85%	13 $1,000
Q2 2020 Aug 11, 2020	SELL	$30.2 - $56.98 $4.27 Million - $8.05 Million	-141,319 Reduced 94.33%	8,495 $472,000
Q1 2020 May 12, 2020	BUY	$24.87 - $38.56 $1.51 Million - $2.34 Million	60,625 Added 67.97%	149,814 $4.44 Million
Q4 2019 Feb 11, 2020	BUY	$25.43 - $36.67 $2.27 Million - $3.27 Million	89,072 Added 76129.91%	89,189 $3.23 Million
Q3 2019 Nov 13, 2019	BUY	$23.0 - $27.97 $598 - $727	26 Added 28.57%	117 $3,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $2,075 - $2,591	91 New	91 $2,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.